• Friday,October 04,2024
gecos.fr
X

Quadruple negative breast cancer

$ 7.00

4.7 (302) In stock

Share

Chris Mason on X: @MeliD32 kicking off #AGBT24 today with an in-depth analysis of cancer disparities, some which started in the 1990s, and how TNBC affects African Americans with higher incidence, earlier

Quadruple-responsive nanoparticle-mediated targeted combination chemotherapy for metastatic breast cancer - Nanoscale (RSC Publishing)

Preclinical evaluation of the AR inhibitor enzalutamide in triple

AR negative triple negative or “quadruple negative” breast cancers in African American women have an enriched basal and immune signature

What Is Triple-Negative Breast Cancer?

Merck's Keytruda gets a foothold in breast cancer market long held by Roche

Microfluidic Systems and Breast Cancer Metastasis

“Quadruple negative” breast cancers in African American women

Journal of Clinical Oncology on X: Quadruple-Negative Breast Cancer: An Uneven Playing Field #JCOGO #bcsm / X

MicroRNAs within Basal-Like Signature of Quadruple Negative Breast Cancer Impact Overall Survival in African Americans[v1]

Triple Negative Breast Cancer: Medical Update

IJMS, Free Full-Text

LncRNA WT1-AS Inhibits Triple-Negative Breast Cancer Cell

The clinical promise of immunotherapy in triple-negative breast